ORMAT TECHNOLOGIES, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $ORA in the last 7 days.
No SEC Form 4 filings for $ORA in the last 30 days.
See all $ORA insider activity →Geothermal energy offers in Nevada undercut solar-plus-storage, with prices at $105-$107/MWh vs. $114/MWh. Google and Amazon are backing geothermal projects. Ormat (ORA) and Fervo (FRVO) are publicly traded geothermal companies, with FRVO's stock down 64% from IPO price.
Ormat Technologies (ORA) plans to drill geothermal test wells in Surprise Valley, CA, sparking community division. Local real estate values are affected, with some residents opposing the project due to environmental concerns, while others support it for economic benefits. The project has state approval and aligns with California's clean energy goals.
Ormat Technologies (ORA) received up to $35 million in funding from the U.S. Department of Energy. The stock closed at $93.07, with a 1-day return of 1.95%, but a 30-day return of -11.74% and a year-to-date return of -18.17%. Analysts estimate a fair value of $127.67, suggesting a 27% undervaluation. However, the P/E ratio of 45.2x raises concerns about overvaluation.
Recent ORA coverage spans financial news and market movers.
Ormat may face short‑term pressure as the market digests lower‑priced geothermal bids, but long‑term upside if contracts expand.
Community pushback and real-estate fallout highlight permitting, stakeholder, and execution risk for Ormat’s planned exploratory drilling.
Funding announcement may lift ORA as investors price in new growth potential.
Neutral rating may limit upside.
Ormat Technologies received up to $35M in DOE funding for geothermal projects. The funding supports its Enhanced Geothermal Systems and carbonate reservoir work, aligning with its core capabilities. Analysts project $1.3B revenue and $224.6M earnings by 2029, with a 37% potential upside. Key risks include high capital expenditure, net debt, and weak interest coverage.
AlphAI scores every news story that mentions ORA with an AI model for sentiment and relevance, and aggregates insider trades from ORMAT TECHNOLOGIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Geothermal energy offers in Nevada undercut solar-plus-storage, with prices at $105-$107/MWh vs. $114/MWh. Google and Amazon are backing geothermal projects. Ormat (ORA) and Fervo (FRVO) are publicly traded geothermal companies, with FRVO's stock down 64% from IPO price.
3 min readOrmat Technologies (ORA) plans to drill geothermal test wells in Surprise Valley, CA, sparking community division. Local real estate values are affected, with some residents opposing the project due to environmental concerns, while others support it for economic benefits. The project has state approval and aligns with California's clean energy goals.
7 min readOrmat Technologies (ORA) received up to $35 million in funding from the U.S. Department of Energy. The stock closed at $93.07, with a 1-day return of 1.95%, but a 30-day return of -11.74% and a year-to-date return of -18.17%. Analysts estimate a fair value of $127.67, suggesting a 27% undervaluation. However, the P/E ratio of 45.2x raises concerns about overvaluation.
2 min readAnalysts this week focused on valuation discipline, trimming winners and cutting stalled growth stories. Key moves: Wells Fargo downgraded FS KKR (FSK) to Underweight with a $10 target, citing credit risks. Stifel upgraded STAAR Surgical (STAA) to Buy, raising its target to $31. Deutsche Bank downgraded Commerzbank (CBKG) to Hold. Citizens downgraded Foghorn Therapeutics (FHTX) after a drug trial failure. UBS downgraded Gurit Holding (GURN) to Neutral.
2 min readOrmat Technologies received up to $35M in DOE funding for geothermal projects. The funding supports its Enhanced Geothermal Systems and carbonate reservoir work, aligning with its core capabilities. Analysts project $1.3B revenue and $224.6M earnings by 2029, with a 37% potential upside. Key risks include high capital expenditure, net debt, and weak interest coverage.
2 min readAnalysts downgraded several stocks: BTIG cut Liquidia (LQDA) to Neutral, BMO reduced Sigma Lithium (SGML) to Market Perform with a $10 target, Wells Fargo downgraded ExxonMobil (XOM) to Equal-Weight with a $182 target, UBS lowered Ormat (ORA) to Neutral with a $100 target, and JP Morgan changed Ethos (LIFE) to Neutral. Prices as of Wednesday's close: LQDA $30.26, SGML $9.40, XOM $162.75, ORA $91.49, LIFE $33.57.
2 min readOrmat Technologies (NYSE:ORA) shares dropped 3.4% after UBS downgraded the stock to Neutral from Buy, cutting its price target to $100 from $157. The downgrade followed Ormat's reduced 2028 adjusted EBITDA guidance and lower growth forecasts. UBS cited limited earnings upside through 2028 and valuation multiples in line with peers.
1 min readWall Street analysts issued updates on various companies. BP (NYSE: BP) was upgraded to Overweight with a $71 target, Dollar Tree (NASDAQ: DLTR) to Buy with a $140 target, and Occidental Petroleum (NYSE: OXY) to Buy with a $69 target. Exxon Mobil (NYSE: XOM) was downgraded to Equal Weight with an $182 target. Other notable initiations and changes include Lennar (NYSE: LEN), Rocket Lab (NASDAQ: RKLB), Teva Pharmaceuticals (NASDAQ: TEVA), and more.
3 min readOrmat Technologies (NYSE: ORA) received up to $35m in US DOE funding for geothermal projects. $25m for EGS project in Nevada, $9.7m for Utah project. Awards pending negotiations. Market cap $5.8B. Stock up 1.2% on news, down 35% from 2026 peak.
1 min readOrmat Technologies (ORA) reported Q2 revenue growth of 10.6% YoY to $258.8M, with energy-storage revenue up 195% YoY. Google (GOOG) agreed to use Ormat's geothermal energy for AI data centers. Ormat is developing enhanced geothermal systems (EGS) with Pentagon interest. The company expects $1.15B-$1.2B revenue in 2026, with a low EV/EBITDA ratio of 16.6x.
3 min read
